{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:02:23Z","timestamp":1781244143971,"version":"3.54.1"},"reference-count":24,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.3892\/mco.2013.118","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:07:23Z","timestamp":1368180443000},"page":"639-642","source":"Crossref","is-referenced-by-count":9,"title":["Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma"],"prefix":"10.3892","volume":"1","author":[{"given":"KOZO","family":"KURIBAYASHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIGERU","family":"MIYATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUYA","family":"FUKUOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKI","family":"MURAKAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SYUSAI","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KUNIHIRO","family":"TAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NORIKO","family":"HIRAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAYUKI","family":"TERADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHIHARU","family":"TABATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIHIRO","family":"FUJIMORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"NAKANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"key":"key20180107151608_b1-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"key20180107151608_b2-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12199-007-0016-7","article-title":"Current therapies for malignant pleural mesothelioma","volume":"13","author":"Nakano","year":"2008","journal-title":"Environ Health Prev Med"},{"key":"key20180107151608_b3-mco-01-04-0639","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in North western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"key20180107151608_b4-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14737140.8.2.293","article-title":"Current concepts in malignant pleural mesothelioma","volume":"8","author":"Kaufman","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107151608_b5-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"key20180107151608_b6-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lungcan.2004.11.003","article-title":"Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary","volume":"48","author":"Maziak","year":"2005","journal-title":"Lung Cancer"},{"key":"key20180107151608_b7-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2006.06.002","article-title":"The role of radiation therapy in malignant pleural mesothelioma: a systematic review","volume":"80","author":"Ung","year":"2006","journal-title":"Radiother Oncol"},{"key":"key20180107151608_b8-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/annonc\/mdi094","article-title":"Chemotherapy options and new advances in malignant pleural mesothelioma","volume":"16","author":"Steele","year":"2005","journal-title":"Ann Oncol"},{"key":"key20180107151608_b9-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"key20180107151608_b10-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107151608_b11-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0065-2571(94)90025-6","article-title":"The methotrexate story: a paradigm for development of cancer chemotherapeutic agents","volume":"34","author":"Huennekens","year":"1994","journal-title":"Adv Enzyme Regul"},{"key":"key20180107151608_b12-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.2174\/1381612033453712","article-title":"Anticancer antifolates: current status and future directions","volume":"9","author":"McGuire","year":"2003","journal-title":"Curr Pharm Des"},{"key":"key20180107151608_b13-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0305-7372(93)90026-N","article-title":"Clinical and preclinical activity of 2\u2032,2\u2032-difluorodesoxycitidine (Gemcitabine)","volume":"19","author":"Lund","year":"1993","journal-title":"Cancer Treat Rev"},{"key":"key20180107151608_b14-mco-01-04-0639","first-page":"1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma","volume":"108","author":"Rusch","year":"1995","journal-title":"From the International Mesothelioma Interest Group Chest"},{"key":"key20180107151608_b15-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"key20180107151608_b16-mco-01-04-0639","unstructured":"National Cancer Institute Common Toxicity Criteria for Adverse Events version 3.0. http:\/\/ctep.cancer.gov\/reporting\/ctc.html Accessed August 9, 2003."},{"key":"key20180107151608_b17-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"key20180107151608_b18-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/bjc.1992.200","article-title":"High-dose methotrexate in the treatment of malignant mesothelioma of the pleura: a phase II study","volume":"65","author":"Solheim","year":"1992","journal-title":"Br J Cancer"},{"key":"key20180107151608_b19-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10120-009-0517-8","article-title":"Efficacy of sequential methotrexate and 5-fluorouracil (MTX\/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination","volume":"12","author":"Imazawa","year":"2009","journal-title":"Gastric Cancer"},{"issue":"Suppl 2","key":"key20180107151608_b20-mco-01-04-0639","first-page":"20","article-title":"Methotrexate and 5-fluorouracil in head and neck cancer","author":"Ringborg","year":"1983","journal-title":"Semin Oncol 10"},{"key":"key20180107151608_b21-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2003.06.122","article-title":"Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma","volume":"21","author":"Scagliotti","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107151608_b22-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.2007.14.7611","article-title":"Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma","volume":"26","author":"J\u00e4nne","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107151608_b23-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mtc.2001.111176","article-title":"The alpha folate receptor is highly activated in malignant pleural mesothelioma","volume":"121","author":"Bueno","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107151608_b24-mco-01-04-0639","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/pbc.21236","article-title":"Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines","volume":"50","author":"Bodmer","year":"2008","journal-title":"Pediatr Blood Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2013.118\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:16:39Z","timestamp":1515338199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2013.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,5,10]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.3892\/mco.2013.118"],"URL":"https:\/\/doi.org\/10.3892\/mco.2013.118","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,10]]}}}